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Previous work revealed that the US (unique short) segment of equine herpesvirus type-1 (EHV-1), like that of other
alphaherpesviruses, encodes a serine/threonine protein kinase (PK). Experiments were carried out to identify the PK
encoded by the EHV-1 EUS2 gene (ORF 69) and to ascertain its time course of synthesis and cellular localization.
Western blot and immunoprecipitation analyses of EHV-1-infected cell extracts using a PK-specific polyclonal antibody
generated against a bacterially expressed TrpE/PK fusion protein identified the US PK as a 42- to 45-kDa phosphoprotein.
The PK protein is first synthesized at 3 hr postinfection, is produced throughout the infection cycle, and is incorporated
into EHV-1 virions. Interestingly, immunoprecipitation analyses revealed that the PK protein within the cytoplasm is
associated with the 33-kDa IR6 novel protein of EHV-1, is expressed abundantly as an early protein, and is present in
the large rod-like structures formed by the IR6 protein (ORF67 protein) within the cytoplasm of infected cells. Confocal
microscopic examination of cells stained with fluorescein-labeled antibody clearly showed that the PK protein colocalized
with the cytoplasmic IR6 rod-like structures and remained associated with these unique structures during infection. In
contrast, in cells infected with the EHV-1 RacM strain in which the IR6 protein harbors four amino acid substitutions
that prevent formation of the rod-like structures (Osterrieder et al., 1996, Virology 217, 442– 451), the PK protein localized
predominantly to the nucleus. The possible significance of the association of the IR6 and PK proteins in EHV-1 replication
is discussed. q 1996 Academic Press, Inc.
INTRODUCTION respectively, while the IR5 protein is a homolog of the
US10 virion protein of HSV-1. The IR6 (Breeden et al.,
Equine herpesvirus type-1 (EHV-1) is a member of the
1992), IR2 (Harty and O’Callaghan, 1991), and IR3 (Holden
Alphaherpesvirinae subfamily and a major pathogen that
et al., 1992a) gene products are not encoded by HSV or
affects equine populations worldwide. EHV-1 infection
other human herpesviruses. The US segment encodesmanifests most often as an upper respiratory infection,
nine major ORFs, four of which encode homologs of HSV
but may also present as an abortagenic disease in preg-
glycoproteins gG, gD, gI, and gE (Colle et al., 1992; Au-
nant mares or as an infection of the central nervous
donnet et al., 1990; Elton et al., 1991; Flowers et al., 1991;
system that leads to paresis and ataxia (Allen and Bry-
Whalley et al., 1991; Telford et al., 1992). The US segment
ans, 1986; Bryans and Allen, 1986; Crabb and Studdert,
also encodes structural protein homologs of HSV-1 US2
1995; Colle et al., 1996). The genome of EHV-1 has a two- and US9 and two ORFs not present in HSV, a putative
isomer structure comprising a unique long (UL) region glycoprotein designated as EUS4 and an ORF encoding
covalently attached to a short region (Henry et al., 1981; a 10-kDa protein (Breeden et al., 1992; Colle et al., 1992;
Whalley et al., 1981). The short region consists of a Telford et al., 1992; Audonnet et al., 1990; Elton et al.,
unique short (US) segment bracketed by two inverted- 1991). Analysis of the predicted amino acid sequence
repeat (IR) segments. Electron microscopic (Ruyechan et encoded by the EUS2 ORF revealed homology to the
al., 1982) and DNA sequence analyses have confirmed serine/threonine protein kinases encoded within the US
this arrangement (Grundy et al., 1989; Flowers et al., segments of other alphaherpesviruses (Colle et al., 1992).
1991, Flowers and O’Callaghan, 1992; Holden et al., The HSV-1 protein kinase (PK) and pseudorabies virus
1992a,b,c; Breeden et al., 1992; Colle et al., 1992; Telford protein kinase (PRV PK) are the most extensively charac-
et al., 1992). Each IR segment was shown to contain six terized of the alphaherpesvirus US protein kinases and
major open reading frames (ORF), IR1 through IR6, and have been shown to function as dimers, although the
three of these encode homologs of herpes simplex virus monomeric units of each PK differ considerably in size
type-1 (HSV-1). The gene products of IR1 and IR4 are (HSV-1 is 68 kDa and PRV is 38 kDa). Each enzyme is
homologs of HSV-1 regulatory proteins ICP4 and ICP22, able to use ATP as a phosphate donor, but not GTP
(Purves et al., 1987; Leader and Katan, 1988; Zhang et
al., 1990), and the intracellular localization of the PK pro-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (318) 675-5764; E-mail: DCALLA@POP3.LSUMC.EDU. teins was shown to be restricted to the cytoplasm of
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infected cells (Purves et al., 1986; Frame et al., 1987; of the PK protein from being predominantly cytoplasmic
to intranuclear.Leader and Purves, 1988). Several substrates for the US
PK have been identified during lytic infection. Purves et
al. (1991) demonstrated that the HSV-1 PK was responsi- MATERIALS AND METHODS
ble for the posttranslational modification of the UL34
Virus and cell culturegene product and that the site of phosphorylation
matched the ideal consensus site predicted from experi- The Ab4p strain of EHV-1 was propagated in NBL-6
ments employing synthetic peptides as substrates. The equine dermis cells and quantitated by plaque assay on
US9 gene product has been reported as a target of the RK-13 cells using established methods for EHV-1 propa-
HSV-2 PK, and the major virion phosphoprotein of PRV gation (O’Callaghan et al., 1968; Perdue et al., 1974). NBL-
has been shown to be phosphorylated by the PRV PK 6 equine dermis cells were obtained from ATCC (CCL
(Daikoku et al., 1994; Zhang et al., 1990). Despite the 57) and maintained in Eagle’s minimal essential medium
identification of several substrates, the function of the US supplemented with 10% fetal calf serum. EHV-1 strain
PK in viral infection is still not fully understood. Deletion Ab4p was kindly provided by Dr. Elizabeth Telford (Insti-
of the US PK has been demonstrated to affect the patho- tute of Virology, University of Glasgow, Glasgow, Scot-
genicity of HSV and PRV in experimental infections using land). EHV-1 strains RacL, RacM 24, and RacM 36 (Oster-
animal models (Kimman et al., 1992; Nishiyama et al., rieder et al., 1996) were kindly provided by Dr. Anton
1992; Kurachi et al., 1993). Mayr (Institute for Medical Microbiology, Infectious and
The EHV-1 US protein kinase is a putative 382-amino- Epidemic Disease, Ludwig – Maximilian– Universita¨t, Mu-
acid protein product (42.5 kDa predicted molecular nich, Germany) and propagated in NBL-6 cells. The RacM
weight) encoded by the 1146-bp EUS2 gene as deter- strains encode an IR6 protein containing four point muta-
mined by DNA sequence analysis (Colle et al., 1992; tions, one or more of which prevent formation of the IR6
Telford et al., 1992). The EUS2 protein possesses nine rod-like structures. These mutations map at residues 34
domains identified by Hanks et al. (1988) as being con- (Ala r Asp), 43 (Ala r Val), 110 (Val r Leu), and 134
served in a comparison of 65 protein kinases of both (Leu r Pro) within the IR6 protein (Osterrieder et al.,
cellular and viral origin as well as a diagnostic sequence 1996).
(Smith and Smith, 1989) that indicates that the EUS2
protein is a member of the serine/threonine class of pro- Generation of viral DNA clones
tein kinases. The EUS2 gene was shown to be tran-
scribed as an early 2.9-kb messenger RNA beginning at EHV-1 DNA subclones were cloned into vectors
pUC18/19 or pBluescript (SK) (/ or 0) (Stratagene, Laapproximately 2 hr postinfection and expressed through-
out the infectious cycle (Colle and O’Callaghan, 1995). Jolla, CA) and were propagated in either Escherichia coli
strains DH5aF* (Bethesda Research Laboratories, Gaith-The US PK gene of other alphaherpesviruses is often
transcribed as a member of a 3*-coterminal family of ersburg, MD) or JM109 (Promega, Madison, WI). The gen-
eration and mapping of most EHV-1 US clones were de-messenger RNAs that includes the message for a down-
stream glycoprotein (Zhang et al., 1990; McGeoch, 1991). scribed previously (Colle et al., 1992; Colle and O’Cal-
laghan, 1995). Construction and cloning of the pATH/PKThis arrangement was demonstrated for EHV-1 US tran-
scripts as the 2.9-kb mRNA of the EHV-1 PK is 3* cotermi- expression subclone were performed by standard tech-
niques (Maniatis et al., 1982). Briefly, clone pRH2, con-nal with the 1.6-kb transcript that encodes the down-
stream putative glycoprotein EUS3, a homolog of HSV-2 taining the majority of the EUS2 (PK) ORF, was digested
with BamHI and SmaI (Bethesda Research Laboratories)gG and PRV gX (Colle and O’Callaghan, 1995).
In this report, we identify the EHV-1 EUS2 gene prod- to release an 846-bp fragment that encodes 282 amino
acids of the EUS2 protein product (residues 37– 318).uct, a homolog of the alphaherpesvirus US protein kinase,
as a 42- to 45-kDa phosphoprotein that is incorporated This fragment was then subcloned into unique BamHI
and HindIII sites of the pATH22 expression vector tointo virions, and we demonstrate that the EUS2 gene
product associates with the EHV-1 IR6 protein shown create an in-frame fusion at the carboxy-terminus of the
trpE gene. The HindIII site 5* overhang was filled in bypreviously to form rod-like structures in the cytoplasm of
infected cells (Breeden et al., 1992; O’Callaghan et al., Klenow DNA polymerase to create a blunt end for ligation
with the SmaI end of the EUS2 fragment. Thus, the pATH/1994; Sun et al., 1995; Osterrieder et al., 1996). The func-
tion of these large intracytoplasmic structures is not PK clone contains a TrpE/PK fusion gene inserted down-
stream of the inducible promoter of the trp operon andknown; however, the findings presented here reveal that
the PK protein readily associates with these structures. encodes a fusion protein of approximately 68 kDa.
The pBluescript/PK (pBSPK) construct was created byFurthermore, mutations within the IR6 protein that pre-
vent the assembly of the rod-like structures (Osterrieder digestion of the pPVUII-B clone, which encompasses the
entire US segment, with SalI and PstI to release a 1440-et al., 1996) also affect the association of the PK protein
with the IR6 protein and thereby change the localization bp fragment containing the complete EUS2 (PK) ORF (US
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nucleotides 591 to 2031; see Colle et al., 1992). This at a concentration of 100 mCi/ml beginning at 1 hr postin-
fection, and extracts were prepared at various timesfragment was then cloned into pBluescript (SK) that had
been digested with SalI and PstI to place the PK ORF postinfection by lysis of the infected cells in 1 ml RIPA
buffer (0.1% SDS, 1% Triton X-100, 1% Na-deoxycholate,under the transcriptional control of a T7 DNA polymerase
promoter. 0.15 M NaCl, 0.01 M Tris– HCl, pH 7.4, 1 mM EDTA)
containing 2.5 mM aprotinin, 2.5 mM leupeptin, and 30
In vitro transcription and translation mg of phenylmethylsulfonyl fluoride per milliliter. Extracts
of mock-infected cells were also prepared as above. Pro-
The pBSPK was in vitro transcribed and translated
tein concentration was determined using the bicincho-
using the TnT coupled reticulocyte lysate system (Pro-
ninic acid (BCA) protein assay reagent (Pierce Chemical
mega), following the manufacturer’s protocol. Briefly, the
Co., Rockford, IL). Unlabeled ICPs were prepared as
PK mRNA was transcribed via the T7 promoter by addition above except radiolabeled isotopes were not added to
of the T7 DNA polymerase and then translated in the the cultures.
presence of [35S]methionine ([35S]Met; New England Nu-
clear, Boston, MA). Labeled proteins were resolved by
Western blot and immunoprecipitation analysesSDS– PAGE analysis through 4% stacking/12% separat-
ing polyacrylamide gels. Gels were dried on a Bio-Rad
Western blot and immunoprecipitation analyses wereModel 583 vacuum drying unit (Bio-Rad, Hercules, CA)
performed as described previously (Flowers and O’Cal-and exposed to XAR5 X-ray film (Kodak, Rochester, NY)
laghan, 1992; Holden et al., 1994; Smith et al., 1992). For
for autoradiography.
Western blot analyses, 20 mg of ICPs was resolved by
SDS – PAGE, and the polypeptides were transferred viaGeneration of the TrpE/PK fusion protein
electroblotting to nitrocellulose filter paper (Schleicher &
The pATH/PK expression construct containing the Schuell, Inc., Keene, NH). The nitrocellulose blots con-
trpE/EUS2 fusion gene was used to transform E. coli TB1 taining the denatured ICPs were blocked for nonspecific
cells, and the fusion protein (TrpE/PK) was isolated as binding by incubation in either 0.5% gelatin or 2% nonfat
described by Koerner et al. (1991) with the modifications dry milk for 30 min. The blots were then incubated with
of McNabb and Courtney (1992) and Harty et al. (1993). the rabbit anti-PK serum at a dilution of 1:1000 or anti-
The 68-kDa TrpE/PK fusion protein was resolved by IR6 antibody (O’Callaghan et al., 1994) at a dilution of
SDS– PAGE in 4%/12% preparative gels, visualized by 1:25,000. The specific protein bands were visualized us-
Coomassie brilliant blue staining, excised, and stored ing a secondary alkaline phosphatase-conjugated, goat
at 0207. anti-rabbit IgG (heavy plus light chains) antibody (Gibco
BRL, Gaithersburg, MD). For immunoprecipitation analy-
Preparation of anti-TrpE/PK serum ses, 10 –20 mg of ICP extracts were first precleared with
preimmune rabbit serum (1:100) in a final volume of 100
Gel slices containing approximately 100 mg of the
ml, and the antibody protein complexes were pelleted
TrpE/PK fusion protein were emulsified in equal volumes
using immobilized rProtein A agarose beads (RepliGen,
of either complete Freund’s adjuvant (primary immuniza-
Cambridge, MA). The EHV-1 PK protein or IR6 protein
tion only; Sigma Chemical Co., St. Louis, MO) or incom-
was immunoprecipitated from precleared radiolabeledplete Freund’s adjuvant (booster immunizations). A fe-
ICP using either the anti-PK serum (1:200) or anti-IR6male New Zealand rabbit (1 kg) was immunized with 0.5-
(1:2500) serum, respectively. The immunoprecipitatedml injections of this emulsion intramuscularly in each
proteins were resolved by SDS– PAGE in 4%/12% gelshindleg. Injections were carried out at 4-week intervals
which were then dried and exposed to XAR5 X-ray filmusing procedures described elsewhere (Harlow and
(Kodak, Rochester, NY) for autoradiography.
Lane, 1988; Harty et al., 1993; O’Callaghan et al., 1994).
Preimmune serum was obtained prior to the beginning
Purification of EHV-1 virionsof the vaccination regime.
Purified virions were prepared from the supernatant ofRadiolabeling and preparation of RK infected cell
Ab4p-infected NBL-6 cells collected at 72 hr postinfectionextracts
as described previously (Perdue et al., 1974). Briefly, viri-
ons in clarified extracellular supernatants were collectedEHV-1 strains Ab4p, RacL, RacM 24, and RacM 36
were used to infect 5 1 106 RK cells at a multiplicity of by polyethylene glycol precipitation and subjected to
three cycles of rate velocity centrifugation in Dextran-10infection (m.o.i.) of 10 PFU/cell, using procedures de-
scribed elsewhere (Caughman et al., 1985; O’Callaghan gradients. The virion protein concentration was deter-
mined using the BCA protein reagent. In the Western blotet al., 1994). Briefly, infected cell polypeptides (ICPs)
were steady-state labeled with [35S]Met or [32P]- analyses of virion protein, 5– 10 mg protein was loaded
in each lane.orthophosphate (32PO4; Amersham, Arlington Heights, IL)
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Indirect immunofluorescence staining and were resolved by SDS – PAGE and visualized by Coomas-
sie blue staining. As expected, TrpE induction producedlaser-scanning confocal microscopy
an abundant 68-kDa protein in the pATH-PK-containing
NBL-6 cells were grown as semiconfluent monolayers TB1 cells that was not present in the uninduced cells or
in two section chamber slides (Nunc, Inc., Naperville, IL). in the soluble fraction of the induced cells (Fig. 1B). This
Cells in one chamber were mock-infected and those in protein was also not found in TB1 cells or in TB1 cells
the other chamber were infected with EHV-1 (either Ab4p, containing the pATH22 vector alone (data not shown).
RacL, RacM 24, or RacM 36) at an m.o.i. of 1 PFU/cell. The The proteins in the insoluble fraction were resolved by
slides were harvested at 3, 6, 9, and 12 hr postinfection, preparative SDS –PAGE, and the 68-kDa protein band
washed in PBS, and then fixed in 100% acetone for 5 was excised and used to produce a rabbit polyclonal
min at 0207. Immunofluorescence staining of infected antiserum against the EHV-1 PK.
cells was done as previously reported (O’Callaghan et To test the specificity of the anti-PK serum produced by
al., 1994). Briefly, slides were rehydrated in PBS for 10 immunization with the TrpE/PK fusion protein, the entire
min at room temperature and blocked with normal goat EUS2 ORF (1145 bp) was cloned into the plasmid pBlue-
serum (NGS; 5% NGS, 0.1% bovine serum albumin in script (SK) (Stratagene) under the control of the T7 DNAPBS) for 30 min in a humidified chamber at room temper- polymerase promoter. This construct allowed the EUS2
ature. Slides containing the fixed mock-infected and protein product to be expressed using a coupled in vitro
EHV-1-infected cells were then incubated with the pri- transcription and translation system (TnT; Promega) in
mary antibody (either rabbit polyclonal anti-PK serum at the presence of [35S]Met (40 mCi). SDS– PAGE analysis of
a dilution of 1:1000 or anti-IR6 serum at a dilution of the total protein translated in the in vitro reaction mixture
1:5000) in 1% NGS, 0.1% BSA in PBS for 1 hr at room revealed a predominant, labeled protein that migrates at
temperature, washed three times in PBS for 10 min each, approximately 42.5 kDa, the predicted size of the EUS2
and then incubated with a fluorescein-conjugated goat protein product, as well as several other proteins of
anti-rabbit immunoglobulin G (heavy plus light chains) lesser amounts and various sizes (Fig. 2). The 42.5-kDa
F(ab*)2 fragments (Pierce). Following three washes in protein was not observed when the parental pBluescript
PBS for 10 min each, slides were overlaid with a mount- (SK/) plasmid was used as template in the in vitro TnT
ing medium of 90% glycerol and 10% PBS containing 1 reaction. The anti-PK serum immunoprecipitated the
mg of p-phenylenediamine per milliliter to reduce fading. 42.5-kDa protein from the in vitro TnT reaction mixture,
Slides were examined in a laser-scanning confocal mi- indicating that the serum was specific for the EUS2 pro-
croscope system (Model MRC1000; Bio-Rad Labora- tein product. A slightly smaller protein species was im-
tories) attached to a Nikon Diaphot microscope and were munoprecipitated by the anti-PK serum and is believed
illuminated with the 488-nm line of a krypton – argon la- to result from initiation of translation at a second internal
ser. Images through the cell were taken at 1-mm intervals in-frame ATG in the PK ORF (Colle et al., 1992). The anti-
with a 601 objective (Nikon 60/1.3). Individual sections PK serum did not react with any protein from the in vitro
were Kalman averaged over three scans and stored on translation of the pBSSK vector alone (Fig. 2). In addition,
a computer. Images were projected using the Bio-Rad control experiments showed antisera to several other
Laboratories COMOS software. A video printer (Sony UP- EHV-1 proteins failed to react with the EUS2 protein.
52000MD) was used to print final images.
Analyses of the EHV-1 US protein kinase in infected
RESULTS cells and virions
Generation of a monospecific polyclonal antiserum
The molecular weight of the EHV-1 PK protein and theagainst the US protein kinase
time course of its synthesis during a lytic infection were
determined by Western blot analyses. NBL-6 equine der-A bacterially expressed TrpE/EUS2 fusion protein was
used as the immunogen to generate rabbit monospecific mis cells infected with EHV-1 strain Ab4p were harvested
at 3, 6, 9, and 12 hr postinfection. The ICPs were resolvedpolyclonal antibody to the EHV-1 EUS2 PK. EUS2 coding
sequences from a BamHI and SmaI fragment were in- by SDS– PAGE, immobilized on nitrocellulose filter paper,
and analyzed with the anti-PK serum. In Western blotserted in frame with the trpE gene in the vector pATH22
(Fig. 1A). The fusion protein was predicted to have a analysis, the anti-PK serum reacted with a single protein
that migrated with an apparent molecular weight of 42–molecular weight of 68 kDa and to express amino acids
37– 318 of the EHV-1 PK (Fig. 1B). The pATH/PK plasmid 45 kDa (Fig. 3A) which is in agreement with the predicted
size of the 382-amino-acid polypeptide encoded by thewas transformed into E. coli strain TB1, and the fusion
protein was induced by tryptophan starvation. The TrpE/ EUS2 ORF (Colle et al., 1992). Expression of this protein
began at 3 hr postinfection, and the protein was readilyPK fusion protein was isolated from total cell lysates of
induced and uninduced cultures that were fractionated detected until at least 24 hr postinfection (Fig. 3B). To
determine if the PK protein is a component of the EHV-into soluble and insoluble fractions, and the proteins
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FIG. 1. Expression of the TrpE/PK fusion protein in E. coli. (A) Diagram of the EHV-1 genome structure. The open boxes show the location of the
US genes EUS1 – EUS5 and the inverted-repeat gene IR6; the arrows (@ or !) indicate the direction of the open reading frame. The location of the
pRH2 and pPVUII-B clones is indicated by the heavy black lines, and the shaded box shows the portion of the EUS2 gene (US base pairs 872–
1718) that was fused to the trpE gene to generate the pATHPK construct. The 3*-coterminal 2.9-kb transcript, encoding the PK protein, and the 1.6-
kb transcript, encoding the EHV-1 gG homolog of HSV-1, are indicated by the lines with arrowheads. (B) Identification of the TrpE/PK fusion protein
expression in E. coli TB1 cells transformed with the pATHPK construct. Top shows the TrpE/PK fusion protein containing amino acids 37 –318 of
the EHV-1 PK and the predicted molecular weight of the fusion protein (68 kDa). T, total cell lysate; S, soluble fraction of total cells; I, insoluble
fraction of the total cell lysate.
1 virion, virions were isolated, purified by established infected cell lysates. Previous work showed that the IR6
protein is also a component of purified EHV-1 virionsmethods (see Materials and Methods), and analyzed by
Western blot analysis using the anti-PK serum (Figs. 3A (O’Callaghan et al., 1994).
and 3B). The data revealed that the EHV-1 PK was associ-
ated with purified EHV-1 virions as a protein with a mo- Confocal immunofluorescence analyses to determine
lecular size identical to that of the protein observed in the intracellular localization of the EHV-1 PK protein
To assess the intracellular localization of the EHV-1 PK
within infected cells, laser-scanning confocal microscopy
was employed. The EHV-1 Ab4p-infected NBL-6 cells
harvested at 3, 6, 9, and 12 hr postinfection were acetone-
fixed and stained using the anti-PK serum and a fluores-
cein-conjugated secondary antibody. Interestingly, the
PK was observed to have a staining pattern identical to
that previously reported for the EHV-1 IR6 protein (Fig.
4; O’Callaghan et al., 1994). Fluorescence observed in
cells fixed at 3 hr postinfection was very weak (data not
shown). However, at 6 hr postinfection, the PK protein
was found to be localized in rod-like structures that ap-
pear to extend from the nucleus to the ends of the fibro-
blast pseudopods in infected NBL-6 cells (Fig. 4B), as
was also observed for the staining pattern of IR6 using
the anti-IR6 serum (Fig. 4E). Coincident with the shrinking
of the cytoplasm, by 9 hr postinfection, both the rod-like
FIG. 2. In vitro expression of the EUS2 (PK) open reading frame. structures of the EHV-1 PK and IR6 proteins condensed
The EUS2 open reading frame was cloned into the pBluescript (SK)
around the nucleus to form the ring-like structure typical(pBSSK/) vector under control of a T7 DNA polymerase promoter to
for the IR6 protein (O’Callaghan et al., 1994) (Figs. 4Cgenerate the pBSPK construct. Both the pBSSK/ vector and pBSPK
construct were used as templates in an in vitro coupled transcription/ and 4F). The PK protein exhibited a distribution pattern
translation reaction, and the protein produced was resolved by SDS – identical to that of the IR6 protein until approximately 12
PAGE. The lanes marked Total show the total protein profile from the hr postinfection, the time of maximal PK protein accumu-
in vitro reactions mixture containing either pBSPK or pBSSK/. Lanes
lation, at which time some faint nuclear staining waslabeled Anti-PK are the protein immunoprecipitated from the total in
observed for the PK (data not shown). Mock-infectedvitro reaction by the anti-PK serum. Marker lanes show approximate
molecular weights. cells exhibited no specific staining with either the anti-
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FIG. 3. Identification of the EHV-1 PK protein in infected cells. (A and B) Western blot analyses of proteins from EHV-1 Ab4p-infected RK cells
harvested at 3, 6, 9, 12, and 24 hr postinfection, from mock-infected (M) cells, and from purified EHV-1 virions (V). Infected cell proteins resolved
by SDS – PAGE were transferred to nitrocellulose then probed with anti-PK serum (1:1000 dilution), and reactive proteins were visualized using a
secondary antibody conjugated to alkaline phosphatase. Marker lanes (MK) show approximate molecular weights. (C) Immunoprecipitation analysis
demonstrating the phosphorylation of the EHV-1 PK protein in Ab4p-infected RK cells. The 42.5-kDa PK protein was immunoprecipitated with anti-
PK serum from [32P]orthophosphate-labeled infected cells harvested at 3, 6, 9, and 12 hr postinfection or from mock-infected cells (M). [32P]Orthophos-
phate (100 mCi/ml) was added at 1 hr postinfection. The immunoprecipitates were resolved by SDS – PAGE and autoradiography. Marker lanes
show molecular weights. The coimmunoprecipitated 33-kDa EHV-1 IR6 protein is also indicated.
PK serum or the anti-IR6 serum at any time postinfection fected cell extracts. At 3 hr postinfection, the anti-PK
(Figs. 4A and 4D). serum immunoprecipitated only the 42- to 45-kDa PK
protein; however, by 6 hr postinfection the 33-kDa protein
Association of the PK and the IR6 phosphoproteins in species was readily coimmunoprecipitated by the anti-
EHV-1 infection PK antibody (Fig. 5A). A more detailed time course analy-
sis revealed that coimmunoprecipitation of the 33-kDaSince the HSV-1 US3 protein kinase is a phosphopro-
protein with the PK protein was first detected at 5 hrtein (Frame et al., 1987), the EHV-1 homolog was ana-
postinfection, but not at any earlier time points (data notlyzed to determine if it shared this feature. Mock-infected
shown). Since the intracellular staining pattern of the PKand EHV-1 Ab4p-infected NBL-6 cells were radiolabeled
in the immunofluorescence analysis was characteristicat 1– 2 hr postinfection with 32PO4 , and cellular extracts
of the EHV-1 IR6 rod-like structures (O’Callaghan et al.,prepared at 3, 6, 9, and 12 hr postinfection were sub-
1994; Sun et al., 1995) and the 33-kDa protein that associ-jected to immunoprecipitation analyses using the anti-
ated with the PK protein was identical in size to the IR6PK serum (Fig. 3C). The results demonstrated that the
phosphoprotein (Breeden et al., 1992; O’Callaghan et al.,PK was indeed a phosphoprotein that was present in
1994), it was believed that the 33-kDa protein was theonly small amounts at 3 hr postinfection; however, by 6
EHV-1 IR6 protein. To determine whether the 33-kDahr a much stronger signal from equivalent amounts of
component was the IR6 protein, the EHV-1 PK/33-kDatotal protein (20 mg) was observed. A second phospho-
complex was immunoprecipitated from Ab4p-infectedprotein species of 33 kDa, first detected at 6 hr postinfec-
cell extracts with the anti-PK serum, resolved by denatur-tion, was also observed to be immunoprecipitated using
ing SDS – PAGE, and then blotted to nitrocellulose filterthe anti-PK serum.
paper. The blot was then probed with anti-IR6 serum (Fig.To investigate the association of the PK and the 33-
5B). Western blot analyses clearly identified the 33-kDakDa phosphoprotein species, EHV-1 Ab4p-infected NBL-
protein associated with the EHV-1 US protein kinase pro-6 cells were steady-state labeled with [35S]Met starting
tein as the IR6 protein since both proteins could be immu-at 1 hr postinfection, and ICPs harvested at 3, 6, 9, and 12
noprecipitated by the anti-PK serum. The anti-PK anti-hr postinfection were subjected to immunoprecipitation
body, however, did not react directly with the IR6 proteinanalyses as described above for the cells labeled with
in Western blot analyses (Fig. 3B), indicating that the32PO4 . The results were similar to those observed in the
immunoprecipitation of the PK from the 32PO4-labeled in- coimmunoprecipitation was not due to cross-reactivity of
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FIG. 5. Western blot analyses of proteins immunoprecipitated by the anti-PK serum demonstrating the association of the EHV-1 PK and IR6
proteins in Ab4p-infected RK cells. (A) Immunoprecipitation analysis demonstrating the coimmunoprecipitation of the EHV-1 PK and IR6 proteins.
Proteins from [35S]Met-labeled, infected cells harvested at 3, 6, 9, and 12 hr postinfection or from mock-infected cells (M) were immunoprecipitated
with anti-PK serum (aPK), and the immunoprecipitates were resolved by SDS– PAGE and autoradiography. Marker lanes (MK) show approximate
molecular weights. (B) Western blot analysis of proteins immunoprecipitated from 12 hr postinfection extracts by the anti-PK serum. The Western
blot was probed with anti-IR6 serum (aIR6; 1:25,000), and reactive proteins were visualized using a secondary antibody conjugated to alkaline
phosphatase. Approximate molecular weights are indicated at the right.
the serum. The anti-IR6 serum could readily coimmuno- therefore the EHV-1 PK is not required for the assembly
precipitate the PK protein. However, the IR6 protein is of the structures (Osterrieder et al., 1996). Equine cells
made in large amounts throughout infection (Breeden et infected either with the RacM mutant virus or with RacL
al., 1992; O’Callaghan et al., 1994), and thus most of the were labeled continuously from 1 hr postinfection with
anti-IR6 antibody reacted with the IR6 protein not associ- [35S]Met and extracts prepared at various times were
ated with the PK protein. subjected to immunoprecipitation analyses with the anti-
PK antibody followed by SDS – PAGE to identify the pro-
In the absence of IR6 rod structures, the US PK teins in the immunoprecipitate. The anti-PK antibody im-
localizes to the nucleus munoprecipitated both the PK protein and the IR6 protein
from the RacL-infected cell extracts, indicating the asso-The IR6 protein of the RacL, KyA, and Ab4p strains of
ciation of these two proteins (Fig. 6A). These results wereEHV-1 readily form rod-like structures in EHV-1-infected
in agreement with those presented in Figs. 3C and 5A.cells (O’Callaghan et al., 1994; Sun et al., 1995). However,
In the case of the extracts of RacM-infected cells, inOsterrieder et al. (1996) demonstrated recently that the
which the IR6 rod-like structures are not formed, the anti-IR6 protein of the EHV-1 RacM strains (RacM 24 and
PK antibody immunoprecipitated only the PK protein (Fig.RacM 36) harbors four point mutations [amino acid resi-
6B), indicating the lack of association of these two pro-dues 34 (Ala r Asp), 43 (Ala r Val), 110 (Val r Leu), and
teins in the RacM-infected cells. Importantly, immunopre-134 (Leu r Pro)] and that one or more of these four
cipitation analyses using the anti-IR6 antibody as a con-mutations prevents the formation of the IR6 protein rod-
trol demonstrated that the IR6 protein was synthesizedlike structures in EHV-1-infected cells.
in the RacM-infected cells and that the anti-IR6 antibodyUsing the RacM strains, it was possible to ascertain
did not cross-react with the PK protein (Fig. 6B).whether the EHV-1 PK protein could associate with the
Interestingly, the failure of the US PK protein to associ-IR6 protein despite its inability to form the rod-like struc-
ate with the IR6 protein in RacM-infected cells radicallytures. The wild-type IR6 protein has been shown to form
rod-like structure in the absence of other viral proteins, altered the intracellular localization of the PK protein dur-
FIG. 4. Laser-scanning confocal analysis of the distribution of the EHV-1 PK and IR6 proteins in EHV-1-infected NBL-6 cells. Equine NBL-6 cells
infected with EHV-1 strain Ab4p at an m.o.i. of 1 were fixed at the times indicated and then stained with either the anti-PK (1:1000) serum or the
anti-IR6 (1:5000) serum. The bar at the right represents pixel intensity (brightness) ranging from none (0) to maximum (255). Details are explained
under Materials and Methods. (A and D) Mock-infected cells fixed at 9 hr postinfection and stained with anti-PK or anti-IR6 serum as indicated. (B
and E) Distribution of the EHV-1 PK and IR6 proteins within infected cells at 6 hr postinfection. (C and F) Distribution of the EHV-1 PK and IR6
proteins within infected cells at 9 hr postinfection.
FIG. 7. Laser-scanning confocal analysis of EHV-1 RacM 24- and RacM 36-infected NBL-6 cells at 9 hr postinfection, demonstrating the altered
intracellular localization of the EHV-1 PK protein in the absence of its association with IR6. Equine NBL-6 cells were infected with either EHV-1
strain RacM 24 or RacM 36 at an m.o.i. of 1 and were fixed at 9 hr postinfection and then stained with either anti-IR6 serum (A, B, E; 1:5000) or
anti-PK serum (C, D, F; 1:1000). The bar at the center represents pixel intensity (brightness) ranging from none (0) to maximum (255). Details are
explained under Materials and Methods. Mock-infected cells were fixed at 9 hr postinfection and stained with either the anti-PK serum or the anti-
IR6 serum as indicated.
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FIG. 6. Immunoprecipitation analysis of proteins by the anti-PK serum from EHV-1 strain RacL-, RacM 24-, or RacM 36-infected RK cells. (A)
Coimmunoprecipitation of the EHV-1 PK and IR6 proteins with anti-PK serum (aPK) from [35S]Met-labeled RacL-infected cells harvested at 3, 6, 9,
and 12 hr postinfection or from mock-infected cells (M). The immunoprecipitates were resolved by SDS – PAGE and autoradiography. Marker lanes
(MK) at left show approximate molecular weights. (B) Immunoprecipitation analysis of extracts harvested at 9 hr postinfection, demonstrating that
in the EHV-1 RacM 24 and RacM 36 infections, aPK does not coimmunoprecipitate the EHV-1 IR6 protein that harbors specific amino acid
substitutions; however, immunoprecipitation with anti-IR6 serum (aIR6) demonstrates that the IR6 protein is present in the infected cell. Mock-
infected cell extracts (M) were also included as controls. The immunoprecipitates were resolved by SDS – PAGE and autoradiography. Marker lanes
show approximate molecular weights. A nonspecific band present in faint amount was also detected in mock-infected cells.
ing lytic infection. Immunofluoresence analysis revealed toskeletal elements such as actin, tubulin, vimentin, des-
min, dynein, or kinesin (O’Callaghan et al., 1994; Oster-that in the absence of PK/IR6 association, the PK protein
localized to, and accumulated within, the nucleus in both rieder et al., 1996). These rod-like structures can be
formed solely by the IR6 protein in the absence of otherRacM 24- and RacM 36-infected cells (Figs. 7C and 7F).
The nuclear staining of the PK protein was first observed viral proteins (Osterrieder et al., 1996) and therefore do
not require the PK protein to initiate or maintain the for-at 6 hr postinfection (data not shown). Figures 7B and
7E illustrate that the IR6 protein in cells infected with mation of these structures.
However, in the EHV-1 RacM strain, specific aminoRacM strains does not form the rod-like structures, but
exhibits a granular distribution in perinuclear vesicles acid substitutions in the IR6 protein prevent formation of
the IR6 rod-like structures and also prevent the associa-which may be part of the endocytic degradation pathway
(Osterrieder et al., 1996). tion of the PK and the IR6 proteins (Osterrieder et al.,
1996). The specific point mutation(s) that prevents the
association of the PK and IR6 proteins is not known. OfDISCUSSION
the four point mutations identified in the IR6 gene of the
Our previous work showed that the EUS2 gene of EHV- RacM strains, it is possible that one or more prevents
1 encodes a protein kinase with significant homology to the association of the PK protein with the IR6 protein,
the unique short protein kinases of other alphaherpesvi- while others affect formation of the rod-like structures.
ruses, such as those of HSV-1 (26% identity) and PRV Identification of which one or more of the four single
(45% identity) (Colle et al., 1992). The 1146-bp ORF is amino acid substitutions within the IR6 protein of the
transcribed to a 2.9-kb messenger RNA that appears by RacM virus prevents formation of the rod-like structures
2 hr postinfection (Colle and O’Callaghan, 1995), a finding is under investigation. This information may reveal
that is consistent with the observation presented here whether domains of the IR6 protein essential for forma-
that the EHV-1 US PK protein is first detected at approxi- tion of the cytoplasmic structures also mediate the inter-
mately 3 hr postinfection as a 42- to 45-kDa phosphopro- action of the IR6 and PK proteins.
tein that becomes incorporated into virions as demon- In the case of EHV-1 RacM-infected cells, it was ob-
strated for the US PK of both HSV-1 and PRV (Zhang et served that the intracellular localization of the EHV-1 PK
al., 1990). The 33-kDa IR6 protein, which does not cross- protein was radically altered as the PK protein accumu-
react with the PK antibody, forms the rod-like structures lated within the nucleus of infected cells. This observa-
and coimmunoprecipitates with the PK protein as shown tion was surprising because the US protein kinases en-
by use of the anti-PK serum. Association of the PK and coded by other alphaherpesviruses localize within the
IR6 proteins was first detected between 4 and 5 hr postin- cytoplasm of infected cells (Purves et al., 1987; Leader
fection, and these proteins were found to associate at and Purves, 1988; Zhang et al., 1990); however, none of
late times after infection. The PK protein colocalizes only the US PK proteins of the other herpesviruses has been
with the IR6 protein that forms rod-like structures in the shown to be complexed with other viral or cellular pro-
cytoplasm of infected cells. No evidence has been found teins that may affect localization of the protein kinase.
The possibility that the IR6 protein complexes were re-to indicate that IR6 associates or colocalizes with cy-
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acting with the rabbit anti-PK antibody directly, such as ate early protein ICP22 (a22) and that this modification
affects the regulatory functions of the ICP22 proteinthrough Fc binding, was eliminated since the anti-PK
antibody failed to react with the IR6 protein in Western (Purves and Roizman, 1992; Purves et al., 1993; Carter
and Roizman, 1996). ICP22-deficient and UL13-deficientblots or to immunoprecipitate the IR6 protein from the
RacM-infected cell extracts. HSV-1 mutants exhibit defects in viral replication that are
cell-type specific and similar to that described above forThe function of the US protein kinases in herpesvirus
infection remains to be defined. However, studies using the PRV US PK deletion mutant. Recently, it has been
suggested that the UL13 protein kinase is an ICP22-de-synthetic peptide substrates have led to the identification
of a putative target site of the PK action for both the HSV- pendent C-terminal domain (CTD) kinase involved in the
modification of the RNA polymerase II CTD during lytic1 and the PRV enzymes. The PK proteins of both of these
herpesviruses prefer peptide substrates that contain sev- HSV-1 infection (Rice et al., 1995) and that this modifica-
tion is required for proper regulation of viral gene expres-eral arginyl residues to the amino-terminal side of the
phosphorylated serine or threonine reside. The ideal tar- sion. Although the EHV-1 US PK protein has greater ho-
mology to the US PK encoded by other alphaherpesvi-get sequence in the synthetic peptides was (R)n-X-
(S/T)VA (Purves et al., 1986; Leader et al., 1991). The ruses (see Colle et al., 1992, Fig. 6) than to the UL13
protein kinases which localize to the nucleus, the EHV-UL34 gene product of HSV-1 has been shown to be post-
translationally modified by the HSV-1 US PK during infec- 1 US PK localizes to the nucleus if its association with
the IR6 protein does not occur as in the case of RacM-tion and to contain an ideal PK recognition sequence
(Purves et al., 1991). Daikoku et al. (1994) have demon- infected cells. The EHV-1 PK protein was shown to be
incorporated into EHV-1 virions and likely encodes thestrated that the US9 gene product, a tegument protein,
is a target of the HSV-2 US PK. Although the US protein serine/threonine protein kinase activity detected in EHV-
1 virions (Randall et al., 1972).kinases of both HSV and PRV have been shown to be
dispensable for growth in tissue culture (Longnecker and A common characteristic of protein kinases is the abil-
ity to autophosphorylate (Leader and Katan, 1988) whichRoizman, 1987), several studies demonstrated a role for
the US PK in in vivo replication. Wagenaar et al. (1995) has been demonstrated for the HSV-1 and PRV US PKs
(Frame et al., 1987; Purves et al., 1987). The US PKs ofreported that infection of porcine nasal mucosa explant
cultures with a PRV US PK deletion mutant affected the both HSV-1 and PRV have been shown to function as
homodimers (Purves et al., 1987; Zhang et al., 1990). Thisability of PRV virions to egress from the nucleus to the
cytoplasm of infected epithelial cells. However, no such may not be the case for the EHV-1 PK which may form
a heterodimer with the unique IR6 protein. Heterodimerdefect was observed in porcine lung alveolar macro-
phages infected with the same knockout virus. These formation would be a unique finding for a herpesvirus
protein kinase; however, no herpesvirus sequenced tofindings suggest that the US PK phosphorylation of a
virion component may be required for proper transport date, other than equine herpesviruses 1 and 4 (Nagesha
et al., 1993) and bovine herpesvirus type 1 (Leung-Tackof the virion through the infected cell, but that this func-
tion may be cell-type specific. In this regard, it is interest- et al., 1994), encodes a homolog of the IR6 protein. IR6
may function as a cofactor required for activation of theing that our ongoing studies suggest that the EHV-1 IR6
protein plays a role in virus egress from the nucleus PK or may simply serve as an anchor to retain the EHV-
1 US PK protein in the cytoplasm.(N. Osterrieder and D. J. O’Callaghan, in preparation).
Phosphorylation of the IR6 protein, possibly by the asso-
ciated US PK, may be important for the IR6 protein to ACKNOWLEDGMENTS
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